/**************************************************/
/* GSK Veeva Master Template - Core Functionality */
/**************************************************/
/* File version              1.8.1                */
/* Last modified             27/11/2019           */
/* Last modified by          Design Center        */
/**************************************************/

var com = com || {};
com.gsk = com.gsk || {};
com.gsk.mtconfig = {
    "localisation": {
        "references": "References",
        "footnotes": "Footnotes",
        "menu": "Menu",
        "pi": "Skrátená informácia o lieku Nucala injekčný roztok",
        "objection": "",
        "custom-menu": "Custom Menu",
        "zoomNote": "Double tap to zoom out",
		"main":"Main",
		"quickRes": "Supporting Documents"
    },
    "presentation": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_MAIN",
    "homepage": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_000",
    "menuPresentation": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_MAIN",
    "menu": "",
    "embedMenu": false,
    "customMenu": [],

    "referencesPresentation": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_MAIN",
    "references": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_REFS",
    "embedReferences": true,
	"embedPopupReferences": true,
    "piPresentation": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_MAIN",
    "pi": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_PI",
    "embedPi": true,
    "importPi": true,
	"quickresPresentation":"",
	"quickres": "",
    "embedQuickRes": false,
	"quickresPerRow": 3,
    "objectionPresentation": "",
    "objection": "",
    "embedObjection": true,
    "importObjection": true,
    "embedGuides": true,
    "portfolioPresentation": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_MAIN",
    "portfolio": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_001",
	"callSummaryPresentation": "",
    "callSummary": "",
    "embedCallSummary": false,
    "veevaSwipe": "0",
    "mtgskPortrait": "0",
    "mtgskUS": true,
    "dialogMaxWidth":89,/*percentage*/
    "dialogMaxHeight":92,/*percentage*/
    "quickLinkDialogWidth": 92,/*percentage*/
    "quickLinkDialogHeight": 92,/*percentage*/
    "quickLinkDialogPortraitWidth": 65.234+"%",
	"quickLinkAutoSize": true,
    "enableQuickLinksOnDialog": true,
    "enableSwipesOnDialog": true,
	"embedRace": false,
    "enableRaceDaysValidation": true,
    "raceDaysCount":-1,
    "raceQuestions":[],
    "raceValues":[],
    "referencesAll": [
        "SPC Nucala 100 mg injekčný roztok v naplnenom pere, Nucala 100 mg injekčný roztok naplnený v injekčnej striekačke – 7/2019.",
        "Khurana S et al. Long-term safety and clinical benefit of mepolizumab in patients with the most severe eosinophilic asthma: the COSMEX study. Clin Ther 2019; 41:2041–2056.",
        "Chupp GL et al. Efficacy of mepolizumab add on therapy on healthrelated quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebocontrolled, parallel-group, multicentre, Phase IIIb trial. Lancet Respir Med 2017; 5:390–400.",
        "Ortega HG et al. Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med 2014; 371:1198–1207.",
        "GlaxoSmithKline data on file. MENSA CSR. REF-3617.",
        "Laidlaw T et al. Efficacy of Mepolizumab in Patients with Severe Eosinophilic Asthma and Concomitant Aspirin-Exacerbated Respiratory Disease: Meta-Analysis of Two Phase III Trials. Am J Respir Crit Care Med 2019; 199:A2672.",
        "Bel EH et al. Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma. N Engl J Med 2014; 371:1189–1197.",
        "Gruber et al. Real-life experience with mepolizumab in the French early access program for severe eosinophilic asthma.European Respiratory Journal Sep 2019, 54 (suppl 63) PA1654; DOI: 10.1183/13993003.congress-2019.PA1654",
        "Harrison et al. Late Breaking Abstract - Effectiveness and safety of mepolizumab in real-world clinical practice: the REALITI-A study. European Respiratory Journal Sep 2019, 54 (suppl 63) OA2104; DOI: 10.1183/13993003.congress-2019.OA2104",
        "Hartl S et al. Blood eosinophil count in the general population: typical values and potential confounders. Eur Respir J 2020; pii: 1901874. doi:10.1183/13993003.01874-2019 [Epub ahead of print].",
        "Denlinger LC et al. Inflammatory and comorbid features of patients with severe asthma and frequent exacerbations. Am J Respir Crit Care Med 2017; 195:302–313.",
        "Felarca AB, Lowell FC. The total eosinophil count in a nonatopic population. J Allergy 1967; 40:16–20.",
        "Lugogo N et al. Long-term efficacy and safety of mepolizumab in patients with severe eosinophilic asthma: a multi-center, open-label, Phase IIIb study. Clin Ther 2016; 38:2058–2070.",
        "Wen T, Rothenberg ME. The regulatory function of eosinophils. Microbiol Spectr 2016; 4 doi: 10.1128/microbiolspec. MCHD-0020-2015.",
        "Weller PF, Spencer LA. Functions of tissue-resident eosinophils. Nat Rev Immunol 2017; 17:746–760.",
        "Bernstein D et al. Usability of mepolizumab single-use prefilled autoinjector for patient self-administration. J Asthma 2019; 28:1–12. doi: 10.1080/02770903.2019.1630641 [Epub ahead of print]."
    ],
    "footnotesAll": [
       
    ],
    "pageReferencesAll": [
		[1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18],
        [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18],
        [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18],
        [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18],
        [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18],
        [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18],
        [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18],
        [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18],
        [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18],
        [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18],
        [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18],
        [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18],
        [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18],
        [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18],
        [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18],
        [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18],
        [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18],
        [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18],
        [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18]
    ],
    "pageFootnotesAll": [
		[]
    ],
    "pagesAll": [
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_000",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_001",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_001.1",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_001.2",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_001.3",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_001.4",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_002",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_003",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_004",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_005",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_006",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_007",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_008",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_009",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_010",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_011",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_012",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_013",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_ver"
    ],
    "pagesTitles": [
		"Nucala_eDetail_Bridge_campaign_2020_MF1.0_000",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_001",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_001.1",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_001.2",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_001.3",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_001.4",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_002",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_003",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_004",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_005",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_006",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_007",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_008",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_009",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_010",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_011",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_012",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_013",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_ver"
    ],
    "pagesDesc": [
		"Nucala_eDetail_Bridge_campaign_2020_MF1.0_000",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_001",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_001.1",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_001.2",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_001.3",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_001.4",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_002",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_003",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_004",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_005",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_006",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_007",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_008",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_009",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_010",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_011",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_012",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_013",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_ver"
    ],
	"menuDesc": [
		"Nucala_eDetail_Bridge_campaign_2020_MF1.0_000",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_001",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_001.1",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_001.2",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_001.3",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_001.4",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_002",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_003",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_004",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_005",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_006",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_007",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_008",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_009",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_010",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_011",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_012",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_013",
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_ver"
    ],
    "addAll": [1, 2, 3, 4, 5, 7, 8, 9, 10, 12, 14, 18],
    "flows": {
        "Main": [0, 6, 11, 13, 15, 16, 17]
    },
    "homeResetsFlows": false,
	"embedpageLock": false, 	 
	"pageLock": [],  
    "subSlides": {},
    "pagesGuides": {},
	"entireOrientation":false,
    "entireOrientationSlide":{
    },
    "orientationLinks": {
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_000": { "slide": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_ver", "presentation": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_MAIN" },
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_001": { "slide": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_ver", "presentation": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_MAIN" },
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_001.1": { "slide": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_ver", "presentation": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_MAIN" },
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_001.2": { "slide": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_ver", "presentation": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_MAIN" },
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_001.3": { "slide": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_ver", "presentation": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_MAIN" },
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_001.4": { "slide": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_ver", "presentation": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_MAIN" },
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_002": { "slide": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_ver", "presentation": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_MAIN" },
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_003": { "slide": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_ver", "presentation": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_MAIN" },
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_004": { "slide": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_ver", "presentation": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_MAIN" },
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_005": { "slide": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_ver", "presentation": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_MAIN" },
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_006": { "slide": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_ver", "presentation": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_MAIN" },
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_007": { "slide": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_ver", "presentation": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_MAIN" },
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_008": { "slide": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_ver", "presentation": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_MAIN" },
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_009": { "slide": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_ver", "presentation": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_MAIN" },
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_010": { "slide": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_ver", "presentation": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_MAIN" },
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_011": { "slide": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_ver", "presentation": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_MAIN" },
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_012": { "slide": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_ver", "presentation": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_MAIN" },
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_013": { "slide": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_ver", "presentation": "Nucala_eDetail_Bridge_campaign_2020_MF1.0_MAIN" }
    },
    "portraitSlides": [
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_ver"
    ],
	"pagesRace": [
    ],
    "maxZoom": 1,
    "pinchToZoomSlides": [],
    "useEmail": true,
	"useShoppingCartEmail":true,
	"emailCartHeader":"Fragments available on this slide",
	"emailCartFooter":"Fragments already selected",
	"emailStatusText":["ADD","REMOVE"],
	"emailTemplateHead":"Choose Template",
    "vaultID": "https://gsk-promomats.veevavault.com",
    "templates": [
        { "label": "Payer's Engagement", "id": 435695 },
        { "label": "Email Template 2", "id": 435994 }
    ],
    "fragments": [
        { "label": "Asthma Studies", "id": 349799 }
    ],
    "pagesEmail": {
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_002": [ 0],
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_003": [ 0 ],
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_004": [ 0 ],
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_005": [ 0 ],
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_007": [ 0 ],
        "Nucala_eDetail_Bridge_campaign_2020_MF1.0_016": [ 40 ]
    },
    "customFragmentSelector": false,
    "customFragmentSelectorContainer": "#fragmentSelector #inner",
	"quickResAll": [],
    "portfolioPresentations": [
    ],
    "presentationsPerRow": 3
};
